Exosome Characterization & Analytical Development Summit
R&D
The Exosome Characterization & Analytical Development Summit (Boston, MA | April 23-25) offers a comprehensive forum, equipping you with the skills needed to establish robust techniques, select the best instruments, ensure quality, and seamlessly navigate regulatory processes.
This hotly anticipated summit will unite expert speakers from Astellas, AbbVie, EV Therapeutics, Exo Biologics, Shift Bio, Vesigen Therapeutics, Harvard Medical School, and many more, to:
- Discover novel data from pioneering companies to benchmark best practices and ensure exosomes are reaching their full potential.
- Build your understanding of how key challenges should be tackled collaboratively, alongside how others are overcoming them with the use of new analytical tools.
- Engage with your peers to drive collaborative initiatives and cultivate impactful partnerships for longevity.
Join us this April for in-depth technical content of exosome analysis, and parameters for confidence in quality.
